Sage Journals: Discover world-class research

Abstract

Background

Poor pain control and opioid use are risk factors for perioperative neurocognitive disorders (PND). The peripheral nerve block (PNB) can reduce pain and opioid consumption. This systematic review aimed to investigate the effects of PNB on PND in older patients with hip fractures.

Methods

The PubMed, Cochrane Central Registers of Controlled Trial, Embase and ClinicalTrials.gov databases were searched from inception until November 19, 2021 for all randomized controlled trials (RCTs) comparing PNB with analgesics. The quality of the selected studies was assessed according to Version 2 of the Cochrane tool for assessing the risk of bias in RCTs. The primary outcome was the incidence of PND. Secondary outcomes included pain intensity and the incidence of postoperative nausea and vomiting. Subgroup analyses were based on population characteristics, type and infusion method of local anesthetics, and type of PNB.

Results

Eight RCTs comprising 1015 older patients with hip fractures were included. Compared with analgesics, PNB did not reduce the incidence of PND in the elderly hip fracture population comprising patients with intact cognition and those with pre-existing dementia or cognitive impairment (risk ratio [RR] = .67; 95% confidence interval [CI] = .42 to 1.08; P = .10; I² = 64%). However, PNB reduced the incidence of PND in older patients with intact cognition (RR = .61; 95% CI = .41 to .91; P = .02; I² = 0%). Fascia iliaca compartment block, bupivacaine, and continuous infusion of local anesthetics were found to reduce the incidence of PND.

Conclusions

PNB effectively reduced PND in older patients with hip fractures and intact cognition. When the study population included patients with intact cognition and those with pre-existing dementia or cognitive impairment, PNB showed no reduction in the incidence of PND. These conclusions should be confirmed with larger, higher-quality RCTs.

Keywords

perioperative neurocognitive disorders nerve block hip fractures elderly

Background

Hip fractures is the most frequent indication for emergency orthopedic surgery in people over 50 years.^1,2 With an expected increase in the elderly population, the incidence of hip fractures is also expected to be the highest in people aged above 65 years.³ Perioperative neurocognitive disorders (PND) are the most common perioperative complications of hip fractures, namely cognitive decline diagnosed preoperatively (known as neurocognitive disorder), any acute event (postoperative delirium), and cognitive decline diagnosed within 30 days after the procedure (delayed neurocognitive recovery) or within 12 months postoperatively (postoperative neurocognitive disorder).⁴ PND prolong the length of hospital stay, increase the incidence of postoperative complications and mortality,⁵ and are associated with the development of dementia later in life.⁶ There are many risk factors for PND, including advanced age, pre-existing cognitive impairment, American Society of Anesthesiologists (ASA) grade 3 or 4,⁷ pain intensity, and opioid use.

Hip fractures cause moderate-to-severe pain.⁸ The analgesic effect of peripheral nerve block (PNB) has been shown in previous studies.^9–11 Compared to opioids and nonsteroidal anti-inflammatory drugs (NSAID), PNB provides precise analgesia, improves patient mobility, and reduces the risk of systemic adverse effects.^12–15

According to a Cochrane systematic review,¹⁶ in adult patients with hip fractures and intact cognition, PNB reduced movement-related pain within 30 min after block placement and decreased the risk of acute confusion. However, most patients with hip fractures are elderly, and half of the patients with hip fractures are diagnosed with pre-existing dementia at >70 years.¹⁷ The effects of PNB on PND in older patients with hip fractures and pre-existing dementia or cognitive impairment are unknown.

Therefore, this systematic review and meta-analysis aimed to determine the effects of PNB on PND, pain relief, and complications in older patients with hip fractures, including patients with intact cognition and those with pre-existing dementia or cognitive impairment, by comparing PNB with other analgesics.

Methods

This review was performed according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines.¹⁸ The protocol for the present meta-analysis was registered before data extraction in the Prospective Register of Systematic Reviews database.

Search Strategy

Electronic databases were searched to identify relevant studies. A systematic search of PubMed, Cochrane Central Registers of Controlled Trial, Embase, and ClinicalTrials.gov were performed from database inception until 19 November 2021 without restrictions on language or publication type. The non-English studies were translated by an online translator. The search was conducted using Medical Subject Headings (MeSH) and the following free text keywords: hip fractures (MeSH), trochanter fractures, subtrochanteric fractures, intertrochanteric fractures, anesthesia conduction (MeSH), nerve block, femoral block, fascia iliaca compartment block, and FICB. The search strategy is provided in the supplementary file.

Study Selection

Two investigators independently reviewed the titles and abstracts to exclude irrelevant studies. The inclusion/exclusion of studies was determined by consensus or discussion with a third review author. Randomized controlled trials (RCTs) were eligible if they met the following criteria for inclusion: (1) patients: elderly patients (≥65 years) with hip fractures, including those involving the femoral head, femoral neck, trochanters, intertrochanteric or subtrochanteric region, (2) intervention: peripheral nerve block of any type performed from the time of injury to the time of discharge, (3) comparison: analgesics of any type (opioids, NSAID, and paracetamol), (4) outcomes: at least one type of PND outcome was assessed using any scale. We excluded (1) studies of patients with polytrauma or those requiring additional surgery apart from hip surgery and (2) ongoing trials or unpublished research.

The primary outcome of this review was PND incidence. The secondary outcomes included pain intensity at various time intervals, assessed using any scale, and incidence of postoperative nausea and vomiting (PONV).

Data Extraction

Two investigators independently extracted the data using a standardized data extraction table. Disagreements were resolved by discussion until consensus was reached or by consulting a third author. The following data were extracted from each eligible study: (1) first author’s name, (2) year of publication, (3) country, (4) study design, (5) patient characteristics (sample size, age, and sex), (6) types of PNB and local anesthetic, (7) intervention period of PNB, (8) the dosage of local anesthetic, (9) injection method of local anesthetic, and (10) outcomes.

Study Quality Assessment

Two investigators independently assessed the quality of the selected studies according to Version 2 of the Cochrane tool for assessing the risk of bias in randomized trials.¹⁹ Disagreements on the risk of bias were adjudicated by a third author. Items were classified under three categories: low, unclear, and high risk of bias. The following characteristics were evaluated: random sequence generation (selection bias); allocation concealment (selection bias); blinding of participants and personnel (performance bias); incomplete outcome data (attrition bias); and selective reporting (reporting bias). All bias results from these questions were graphed and assessed using Review Manager 5.4.1 (Review Manager [RevMan], Version 5.4.1, Cochrane Collaboration, 2020).

Statistical Analysis

Statistical analysis of the pooled data was performed using Review Manager version 5.4.1 (RevMan, Version 5.4.1, Cochrane Collaboration, 2020), and the random-effects model was used to analyze continuous and dichotomous outcomes. Weighted mean difference (WMD) with a 95% confidence interval (CI) was calculated for continuous outcomes, and risk ratio (RR) with a 95% CI was calculated for dichotomous outcomes. P < .05 was regarded as statistically significant. Heterogeneity between studies was quantified using the I² statistic, and significant heterogeneity was deemed present for I² >50% and P < .1. Subgroup analyses were performed to investigate the heterogeneous control interventions. Subgroup analysis was based on the population characteristics of studies (older patients with hip fractures with intact cognition vs older patients with hip fractures including those with intact cognition and those with pre-existing dementia or cognitive impairment), types of PNB (fascia iliaca compartment block [FICB] vs femoral nerve block [FB]), PNB infusion methods (single injection vs continuous infusion), and types of local anesthetic (ropivacaine vs bupivacaine). Publication bias was assessed using funnel plots. In addition, the sensitivity analysis were performed to investigate the influence of individual studies on the pooled results by excluding differences in PND types and two perioperative period phases in which local anesthetics were administered.

Results

Study Selection

The database search yielded 1911 studies. A total of 1213 abstracts were screened after removing duplicates. After screening, 91 potentially relevant studies were included and 72 were excluded because they were considered irrelevant for this review. Nine studies^20–28 did not fulfil the inclusion criteria, and data from two studies^29,30 could not be extracted. Eight studies^31–38 comprising 1015 older patients with hip fractures were included in this systematic review and meta-analysis. The included studies were published between 2007 and 2021. PNB was administered to 512 older patients, whereas 503 older patients received analgesics for hip fractures. The trial selection process was illustrated in Figure 1.

Figure 1.

The flowchart for study screening and selection process according to the PRISMA guidelines.

Study Characteristics

Table 1 presents the features highlighted in this study. The mean age of the study participants ranged from 84.9 to 72.3 years. Seven studies^{31–33,35–38} provided data on the incidence of delirium or confusion, one³³ of which reported data on the incidence of preoperative delirium and postoperative delirium after PNB intervention. The incidence data of postoperative delirium were retained for this review. One of the seven studies³⁸ also reported data on the degree of cognitive decline. Only one study³⁴ reported data on the incidence of cognitive decline. Five studies^{31,32,35,37,38} included older patients with hip fractures and intact cognition, and three studies^33,34,36 included older patients with hip fractures and both intact cognition and pre-existing dementia or cognitive impairment. In four studies, FICB were used.^34–37 In three studies, FB were used.^32,33,38 And in one study, lumbar-sacral plexus block was used.³¹ In all of the studies, single-injection local anesthetic were provided for the block; in four studies^32,35,37,38 continuous infusion after the single injection were provided. Two studies^35,37 reported that local anesthetic were administered continuously during two phases of the perioperative period, and in six studies,^{31–34,36,38} local anesthetic were administered during only one phase of the perioperative period. The local anesthetic used in four studies^31,34,35,38 were ropivacaine, in three studies^32,36,37 were bupivacaine, and in one study³³ was levobupivacaine. Five studies^{33–35,37,38} used opioids in the control group. Six studies^{31,32,35–38} provided data regarding analgesic effects at various time intervals. Two studies^31,35 provided data on static and dynamic pain scores, and dynamic pain scores were retained for this review. Seven studies^31,33–38 provided data on complications. Three studies^31,36,38 reported the incidence of PONV. One study³¹ reported the incidences of PONV at the 24 hours and 48 hours, but we retained the data for the 48 hours in this review.

Table 1.

Study Characteristics of all Studies Included in this Systematic Review.

Trial	Country	Design	Mean age (years)		Number of Patients		PNB Group				Control Group	Outcomes	Measurement Timepoint
Trial	Country	Design	PNB	Control	PNB	Control	PNB Type	Intervention Period	Local Anaesthetic	Infusion Dose/interval	Control Group	Outcomes	Measurement Timepoint
Cuvillon [38], 2007	France	RCT 3 arms	83 ± 5	83 ± 7 81 ± 8	21	21 20	FB	Postoperative	Ropivacaine	30 mL 1.5% adrenaline lidocaine/single, .2%/ mLh⁻¹/continuous infusion 48 h	Morphine group: SC morphine, .05 mg/kg per 4 h, IV morphine titration was performed, followed by subcutaneous morphine every 4 h according to VAS >30 Propacetamol group: IV 2 g propacetamol/6 h	Pain, degree of cognitive decline, complications, mortality	Post-anaesthetic care unit, 4 h, 8 h, 12 h, 16 h, 20 h, 24 h, 28 h, 32 h, 36 h, 40 h, 44 h, 48 h, mortality at 6 months
Mouzopoulos [37], 2009	Greece	RCT 2 arms	72.3 ± 4.1	73.1 ± 3.8	102	105	FICB	Preoperative, postoperative	Bupivacaine	.25%/0.3 mL.kg⁻¹/24 h, repeated every 24 h	Ampules for IV infusion of paracetamol, 1g/6.7 mL and IM pethidine (50 mg) occasionally as needed	Perioperative delirium, pain, complications		In-hospital
Godoy Monzón [36], 2010	Argentina	RCT 2 arms	73.5 ± 3.29	79.4 ± 3.38	92	62	FICB	Preoperative	Bupivacaine	.25%/0.3 mL.kg⁻¹/single	IV NSAID (diclofenac or ketorolac, depending on their medical history)	Pain, delirium, complications		15 min after treatment, 2 h after treatment, 8 h after treatment
Uysal [32], 2019	Turkey	RCT 2 arms	81.41 ± 8.06	82 ± 6.83	46	45	FB	Preoperative	Bupivacaine	.25% 10 mL, .25%/0.5 mL.kg⁻¹/repeated every 8 h	IV 15 mg/kg paracetamol within 15 min. Paracetamol treatment was repeated every 8 hours in surgical ward	Pain, delirium		Position, 1 h, 4 h, 12 h, 24 h
Loessin [35], 2019	Canada	RCT 2 arms	–	–	15	15	FICB	Preoperative, intraoperative	Ropivacaine	.125% 40 mL/single, 2%/10 mL/h, .125%/40 mL/single	IV opioids and NSAID and paracetamol	Complications, pain, delirium, mortality		Pre-enrolment, enrolment, preoperative, discharge, mortality at 30 days
Wennberg [34], 2019	Sweden	RCT 2 arms	84.6 ± 6.7	84.9 ± 7.7	65	60	FICB	Preoperative	Ropivacaine	2 mg.mL⁻¹/30 mL/single	IV morphine, paracetamol	Postoperative cognitive status, pain, complications		In-hospital
Unneby [33], 2020	Sweden	RCT 2 arms	83.7 ± 7.1	84.4 ± 6.4	116	120	FB	Preoperative	Levobupivacaine	.25%/40 mL/single	IV morphine if required	Perioperative delirium, complications, pain		In-hospital
Tang [31], 2021	China	RCT 2 arms	76.6 ± 6.98	78 ± 6.45	55	55	Lumbosacral plexus block	Intraoperative	Ropivacaine	.25%/20 + 20 mL/single	Unilateral spinal anaesthesia and light sedation (BIS 60-80) was maintained by adjusting the effect-site concentration of propofol	Delirium, pain, complications		24 h; 48 h; 72 h

BIS, bispectral index; FB, femoral nerve block; FICB, fascia iliaca compartment block; IM, intramuscular; IV, intravenous; NSAID, nonsteroidal anti-inflammatory drugs; PNB, peripheral nerve block; RCT, randomised controlled trial; SC, subcutaneous; VAS, visual analogue scale.

Risk of Bias Within Studies

We assessed the risk of bias in each study using Version 2 of the Cochrane tool for assessing the risk of bias in RCTs (Figure 2 and 3). One study³⁶ had a high risk of performance bias. Five studies^{31–33,35,38} did not clearly describe the blinding processes for participants and personnel, and we considered these studies to have an unclear risk of bias. Four studies^31,32,35,37 had unclear descriptions of allocation concealment, three studies^32,33,35 had unclear descriptions of blinding of outcome assessment, and two studies^32,35 did not provide a clear description of random sequence generation. These studies were deemed to have an unclear risk of bias. All studies reported satisfactory outcome data and were considered to have a low risk of attrition.

Figure 2.

Proportions of studies with categories for risk of bias.

Figure 3.

Summary for the risk of bias in each study.

Synthesis of Results

To obtain sufficient data points for a meta-analysis, only the following measurements were included: PND, PONV, and the analgesic effects at the 4 hours, 12 hours, 24 hours, and 48 hours after surgery. Funnel plots were not used to detect publication bias because only eight studies were included in this systematic review.

Primary Outcome

Compared to analgesics, PNB did not significantly affect the incidence of PND in older patients with hip fractures (RR = .67; 95% CI = .42 to 1.08; P = .10; I² = 64%) (Figure 4). The sensitivity analyses revealed stable results (Table 2). Exclusion of the study³⁴ that reported data on the incidence of cognitive decline and two studies^35,37 in which local anesthetics were administered continuously during two phases of the perioperative period did not alter the results. Heterogeneity of the above results was evident from the I² values (>50%).

Figure 4.

Forest plot of the incidence of perioperative neurocognitive disorders.

Table 2.

Sensitivity Analysis for PND Outcome.

	PND Risk Ratio (95% CI)
All studies	.67 (.42, 1.08)
Selected studies omitted
Wennberg [34], 2019	.70 (.43, 1.16)
Loessin [35], 2019
Mouzopoulos [37], 2009	.75 (.46, 1.24)

PND, perioperative neurocognitive disorders.

The results of the subgroup analyses were presented in Table 3. The results suggested that PNB reduced the incidence of PND in elderly patients with hip fractures with intact cognition (RR = .61; 95% CI = .41 to .91; P = .02; I² = 0%) but did not reduce the incidence of PND in elderly patients with hip fractures that included patients with intact cognition and those with pre-existing dementia or cognitive impairment (RR = .58; 95% CI = .18 to 1.84; P = .35; I² = 68%). Compared with analgesics, FICB reduced the incidence of PND (RR = .45; 95% CI = .26 to .76; P = .003; I² = 0%), but FB did not reduce the incidence of PND in elderly patients (RR = .82; 95% CI = .50 to 1.37; P = .45; I² = 53%). Regarding the injection methods of local anesthetic, continuous infusion reduced the incidence of PND (RR = .53; 95% CI = .35 to .82; P = .004; I² = 0%), but the single injection did not (RR = .84; 95% CI = .43 to 1.63; P = .60; I² = 51%). Concerning local anesthetic types, bupivacaine reduced the incidence of PND (RR = .45; 95% CI = .26 to .77; P = .004; I² = 0%), whereas ropivacaine did not (RR = .72; 95% CI = .43 to 1.19; P = .20; I² = 0%).

Table 3.

Subgroup Analysis of PND Outcome.

Outcome	Trials	Participants	Risk Ratio (95% CI)	P Values	I², %
Population characteristics of studies
Elderly hip fracture patients with intact cognition	5	500	.61 (.41, .91)	.02	0
Elderly hip fracture patients including those with intact cognition and those with pre-existing dementia/cognitive impairment	3	515	.58 (.18, 1.84)	.35	68
Types of PNB
FICB	4	516	.45 (.26, .76)	.003	0
FB	3	389	.82 (.50, 1.37)	.45	53
Injection methods of local anaesthetic
Single injection	4	625	.84 (.43, 1.63)	.60	51
Continuous infusion	4	390	.53 (.35, .82)	.004	0
Types of local anaesthetic
Ropivacaine	4	327	.72 (.43, 1.19)	.20	0
Bupivacaine	3	452	.45 (.26, .77)	.004	0

PND, perioperative neurocognitive disorders; FICB, fascia iliaca compartment block; FB, femoral nerve block.

Secondary Outcomes

Data of pain intensity assessed using visual analogue scale (VAS) scores at the 4 hours (WMD = .55; 95% CI = −.79 to 1.89; P = .42; I² = 63%), 12 hours (RR = −1.53; 95% CI = −5.78 to 2.27; P = .48; I² = 96%), 24 hours (RR = .78; 95% CI = −.23 to 1.79; P = .13; I² = 78%), and 48 hours after surgery (RR = .43; 95% CI = −1.56 to 2.43; P = .67; I² = 84%) did not show significant differences between PNB and analgesics (Table 4). Compared with analgesics, PNB did not reduce the incidence of PONV (RR = 1.10; 95% CI = .27 to 4.60; P = .89; I² = 60%) (Figure 5).

Table 4.

Comparison of Analgesic Effect at Various Time Intervals Between the PNB and Control Groups.

Outcome	Trials	Participants	WMD (95% CI)	P Values	I², %
VASscores at 4 hours after surgery	2	153	.55 (−.79, 1.89)	.42	63
VAS scoresat 12 hours after surgery	2	153	−1.53 (−5.78, 2.27)	.48	96
VAS scoresat 24 hours after surgery	3	263	.78 (−.23, 1.79)	.13	78
VAS scoresat 48 hours after surgery	2	172	.43 (−1.56, 2.43)	.67	84

Effect size values of VAS scores expressed as WMD. PNB, peripheral nerve block; VAS, visual analogue scale; WMD, weighted mean difference.

Figure 5.

Forest plot of the incidence of postoperative nausea and vomiting.

Discussion

Our study showed that PNB reduced PND in elderly patients with hip fractures and intact cognition. However, there was no significant difference between PNB and analgesics with regards to reducing the incidence of PND in the elderly population with hip fractures. The incidences of PONV and pain reduction did not differ significantly between the PNB groups and analgesics groups.

This systematic review differs from a recent systematic review¹⁶ in that it included RCTs involving patients with pre-existing dementia or cognitive impairment. The populations of studies which exclude patients with pre-existing dementia or cognitive impairment might not reflect routine clinical practice. An increase in the proportion of elderly patients with hip fractures will also result in an increase in the proportion of patients with hip fractures with pre-existing dementia or cognitive impairment. In this review, three studies included patients with intact cognition and those with pre-existing dementia or cognitive impairment. Subgroup analyses of these three studies, which included 515 patients, showed that PNB did not reduce the incidence of PND. Compared to patients with intact cognition, when these patients have hip fractures, there is a high probability that their analgesic treatment will be inadequate.³⁹ A previous study showed that only 24% of the patients with dementia or cognitive impairment received appropriate pain treatment.⁴⁰ One reason is the presence of difficulties in communication with such patients who are unable to express the need for pain relief accurately and promptly.⁴¹ Another reason is when using analgesics, medical personnel have difficulty assessing the level of pain in those with dementia or cognitive impairment.⁴⁰ Accordingly, improved methods are required to objectively assess pain levels in these patients. In addition, more high-quality studies related to pre-existing dementia or cognitive impairment are required.

Our results showed that PNB reduced the incidence of PND in the elderly patients with hip fractures and intact cognition. This was consistent with the results of other studies involving such patients.¹⁶ PNB influenced PND, which was associated with reduced pain on movement, reduced opioid consumption and early mobilization.^42–44 However, in this review, we did not find any analgesic advantage of PNB over analgesics. This was probably because of the variable time intervals for reporting VAS scores and the clinical heterogeneity between studies. Only the data of 2-3 studies were included in the meta-analysis, and the samples sizes were not sufficient enough to allow definitive conclusions on the analgesic effect of PNB.

The association of injection methods of local anesthetic with their analgesic effect is controversial. This review showed that continuous infusion of local anesthetic reduced the incidence of PND in elderly patients as compared with the single injection. A possible explanation for the decline in the incidence of PND may be that continuous infusion of local anesthetic offers increased pain control, decreased opioid consumption, and reduced PONV.^45,46 Concerns regarding continuous infusion were primarily related to complications. However, in the studies included in this review, only one study³⁷ observed local hematomas associated with nerve block. Three local hematomas were reported in this study of 102 FICB procedures, resulting in an incidence of 2.9%, which was similar to the 1.7% reported in a previous review.¹²

The most optimal PNB modality for hip fractures is undetermined.⁴⁷ In terms of anatomy, hip innervation includes the lateral cutaneous nerve of the thigh, femoral nerve, and obturator nerve. The fascia iliaca compartment is the space under the fascia iliaca, where the femoral, obturator, and lateral cutaneous nerves are located, with the injection site being far from the nerves or blood vessels. Although FB is recognized as an effective method,⁴⁸ FICB has a wider range of blockade than FB alone and provides a better analgesic effect.^29,43 In particular, FICB can simultaneously block the lateral cutaneous nerve of the thigh and femoral nerves more effectively.⁴⁹ Additionally, there are different types of hip fractures. Surgical treatment involves either internal fixation of the fracture or total or partial replacement of the joint with arthroplasty. A study¹⁵ showed that FICB had an advanced analgesic effect in patients with femoral neck fractures, but no obvious analgesic effect in patients with intertrochanteric fractures. This result suggests that fracture location might affect the efficacy of FICB or FB. Further homogeneous studies are required to confirm this conclusion.

In addition, the administration of ropivacaine does not show the same advantage as bupivacaine in reducing the incidence of PND in elderly patients with hip fractures. Ropivacaine produces a less potent motor blockade but an equally effective sensory block to dose-equivalent bupivacaine.⁵⁰ In this review, the concentration of bupivacaine reported in three studies were .25%, and that of ropivacaine reported in four studies were .125%–.25%. As the efficacy of a local anesthetic was closely related to its concentration,⁵¹ the differences in drug concentrations might explain the negative results in the ropivacaine group.

Further, PONV is a known side effect of opioids. In three studies that reported PONV data, only one control group used morphine, whereas the other groups used non-opioid analgesics. The incidences of PONV were low in the PNB and control groups, with no significant differences between the groups.

This meta-analysis has some limitations. First, only eight trials met the inclusion criteria, and only two included more than 100 patients. Many trials had an unclear risk of bias; therefore, the possibility of bias in this systematic review cannot be ignored. Second, there was a risk of publication bias because of the limited number of trials. Third, there existed heterogeneity within some subgroups, and the lack of standardization of PNB treatment protocols limited our findings. Analgesic efficacy and PONV outcomes were also characterized by a high degree of heterogeneity. This could be attributable to the small number of included studies, lack of a standardized time interval for the assessment of analgesic effects, and paucity of complication data, which limited the interpretation and applicability of the results. These limitations should be addressed by larger, higher-quality RCTs.

Conclusion

The result of this systematic review and meta-analysis demonstrated that PNB was advantageous in reducing PND in older patients with hip fractures and intact cognition. FICB, bupivacaine, and continuous infusion of local anesthetic were beneficial for reducing PND in elderly patients with hip fractures and intact cognition or pre-existing dementia or impairment.

In both groups of patients, there were no differences between PNB and analgesics in terms of reducing PND, pain, and PONV. In addition, there were insufficient evidence to draw conclusions regarding the efficacy of FB, ropivacaine, and the single injection of local anesthetic in reducing PND.

Footnotes

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

PROSPERO Registration Number

CRD42022310852

ORCID iDs

Xiangyu Li

Yongyong Shi

Data Availability Statement

The that support the findings of this study are available from the corresponding author upon reasonable request.

References

Raheman

Rojoa

Nayan Parekh

Berber

Ashford

. Meta-analysis and metaregression of risk factors associated with mortality in hip fracture patients during the COVID-19 pandemic. Sci Rep. 2021;11:10157.

Garofoli

Maravic

Ostertag

Cohen-Solal

. Secular trends of hip fractures in France: Impact of changing characteristics of the background population. Osteoporos Int. 2019;30:355-362.

Brown

Starr

Nunley

. Analysis of past secular trends of hip fractures and predicted number in the future 2010-2050. J Orthop Trauma. 2012;26:117-122.

Evered

Silbert

Knopman

, et al. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018. Br J Anaesth. 2018;121:1005-1012.

Leslie

Inouye

. The importance of delirium: Economic and societal costs. J Am Geriatr Soc. 2011;59(Suppl 2):S241-S243.

Marcantonio

Flacker

Michaels

Resnick

. Delirium is independently associated with poor functional recovery after hip fracture. J Am Geriatr Soc. 2000;48:618-624.

Smith

Cooper

Peryer

Griffiths

Fox

Cross

. Factors predicting incidence of post-operative delirium in older people following hip fracture surgery: A systematic review and meta-analysis. Int J Geriatr Psychiatry. 2017;32:386-396.

Foss

Kristensen

Bundgaard

, et al. Fascia iliaca compartment blockade for acute pain control in hip fracture patients: A randomized, placebo-controlled trial. Anesthesiology. 2007;106:773-778.

Hughes

Boncyk

Culley

, et al. American society for enhanced recovery and perioperative quality initiative joint consensus statement on postoperative delirium prevention. Anesth Analg. 2020;130:1572-1590.

10.

Steenberg

Møller

. Systematic review of the effects of fascia iliaca compartment block on hip fracture patients before operation. Br J Anaesth. 2018;120:1368-1380.

11.

Hong

. The efficacy of fascia iliaca compartment block for pain control after hip fracture: A meta-analysis. Medicine (Baltimore). 2019;98:e16157.

12.

Scurrah

Shiner

Stevens

Faux

. Regional nerve blockade for early analgesic management of elderly patients with hip fracture-a narrative review. Anaesthesia. 2018;73:769-783.

13.

Anger

Valovska

Beloeil

, et al. PROSPECT guideline for total hip arthroplasty: a systematic review and procedure-specific postoperative pain management recommendations. Anaesthesia. 2021;76:1082-1097.

14.

Hamilton

Lalu

Ramlogan

, et al. A population-based comparative effectiveness study of peripheral nerve blocks for hip fracture surgery. Anesthesiology. 2019;131:1025-1035.

15.

Garlich

Pujari

Moak

, et al. Pain management with early regional anesthesia in geriatric hip fracture patients. J Am Geriatr Soc. 2020;68:2043-2050.

16.

Guay

Kopp

. Peripheral nerve blocks for hip fractures in adults. Cochrane Database Syst Rev. 2020;11:CD001159.

17.

Karlsson

Berggren

Gustafson

Olofsson

Lindelöf

Stenvall

. Effects of geriatric interdisciplinary home rehabilitation on walking ability and length of hospital stay after hip fracture: A randomized controlled trial. J Am Med Dir Assoc. 2016;17:464.e9-464.e15.

18.

Moher

Liberati

Tetzlaff

Altman

PRISMA Group . Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ. 2009;339:b2535.

19.

Sterne

JAC

Savović

Page

, et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.

20.

Chaudet

Bouhours

Rineau

, et al. Impact of preoperative continuous femoral blockades on morphine consumption and morphine side effects in hip-fracture patients: A randomized, placebo-controlled study. Anaesth Crit Care Pain Med. 2016;35:37-43.

21.

Wang

Dai

, et al. Ultrasound-guided multiple nerve blocks: A safe and effective anesthetic modality in geriatric hip fracture patients. Clin J Pain. 2021;37:881-886.

22.

Carvalho

Palha Ribeiro

Vasconcelos

. Proximal femur fracture anesthesia technique-does it really matter? Reg Anesth Pain Med. 2021;70(Suppl 1):A47.

23.

Bielka

Kuchyn

Tokar

Artemenko

Kashchii

. Psoas compartment block efficacy and safety for perioperative analgesia in the elderly with proximal femur fractures: A randomized controlled study. BMC Anesthesiol. 2021;21:252.

24.

Luo

Lei

, et al. The effect of the fascia iliaca compartment block combined with laryngeal mask general anesthesia on the internal fixation of senile femoral neck fracture. Int J Clin Exp Med. 2020;13:634-643.

25.

Yamamoto

Sakura

Noda

, et al. Comparison of the postoperative analgesic efficacies of intravenous acetaminophen and fascia iliaca compartment block in hip fracture surgery: A randomised controlled trial. Injury. 2019;50:1689-1693.

26.

Hao

Dong

Zhang

Luo

. Pre-emptive analgesia with continuous fascia iliaca compartment block reduces postoperative delirium in elderly patients with hip fracture. A randomized controlled trial. Saudi Med J. 2019;40:901-906.

27.

Nie

Yang

Wang

Liu

Zhao

Luan

. Effects of continuous fascia iliaca compartment blocks for postoperative analgesia in patients with hip fracture. Pain Res Manag. 2015;20:210-212.

28.

White

Chappell

. Anaesthesia for surgical correction of fractured femoral neck. A comparison of three techniques. Anaesthesia. 1980;35:1107-1110.

29.

Xue

Lan

Wang

. Ultrasound-guided continuous fascia iliaca compartment block for pre-operative pain control in very elderly patients with hip fracture: A randomized controlled trial. Exp Ther Med. 2018;16:1944-1952.

30.

Yang

Chen

Zheng

Yang

Huang

Cui

. Abstract PR343: Ultrasound guided continuous fascia iliaca block for pain management in elder patients with hip fractures. Anesth Analg. 2016;123:440-441.

31.

Tang

Fang

Liu

. Comparison of effects between combined lumbar-sacral plexus block plus general anesthesia and unilateral spinal anesthesia in elderly patients undergoing hip fracture surgery: a pilot randomized controlled trial. Evid Based Complement Alternat Med. 2021;2021:6685497.

32.

Uysal

Aİ

Altıparmak

Yaşar

, et al. The effects of early femoral nerve block intervention on preoperative pain management and incidence of postoperative delirium geriatric patients undergoing trochanteric femur fracture surgery: A randomized controlled trial. Ulus Travma Acil Cerrahi Derg. 2020;26:109-114.

33.

Unneby

Svensson

Gustafson

Lindgren

APB

Bergström

Olofsson

. Complications with focus on delirium during hospital stay related to femoral nerve block compared to conventional pain management among patients with hip fracture-A randomised controlled trial. Injury. 2020;51:1634-1641.

34.

Wennberg

Möller

Herlitz

Kenne Sarenmalm

. Fascia iliaca compartment block as a preoperative analgesic in elderly patients with hip fractures-effects on cognition. BMC Geriatr. 2019;19:252.

35.

Loessin

El Zahabi

Brownbridge

Bajwa

. Continuous fascia iliaca block for acute hip fractures: A randomized-controlled pilot study. Can J Anaesth. 2019;66:1265-1267.

36.

Godoy Monzón

Vazquez

Jauregui

Iserson

. Pain treatment in post-traumatic hip fracture in the elderly: Regional block vs. systemic non-steroidal analgesics. Int J Emerg Med. 2010;3:321-325.

37.

Mouzopoulos

Vasiliadis

Lasanianos

Nikolaras

Morakis

Kaminaris

. Fascia iliaca block prophylaxis for hip fracture patients at risk for delirium: A randomized placebo-controlled study. J Orthop Traumatol. 2009;10:127-133.

38.

Cuvillon

Ripart

Debureaux

, et al. [Analgesia after hip fracture repair in older patients: The effect of a continuous femoral nerve block: A prospective and randomised study]. Ann Fr Anesth Reanim. 2007;26:2-9.

39.

Lundström

Olofsson

Stenvall

, et al. Postoperative delirium in old patients with femoral neck fracture: A randomized intervention study. Aging Clin Exp Res. 2007;19:178-186.

40.

Morrison

Siu

. A comparison of pain and its treatment in advanced dementia and cognitively intact patients with hip fracture. J Pain Symptom Manage. 2000;19:240-248.

41.

Holdgate

Shepherd

Huckson

. Patterns of analgesia for fractured neck of femur in Australian emergency departments. Emerg Med Australas. 2010;22:3-8.

42.

Stein

Srikumaran

Tan

Freehill

Wilckens

. Lower-extremity peripheral nerve blocks in the perioperative pain management of orthopaedic patients: AAOS exhibit selection. J Bone Joint Surg Am. 2012;94:e167.

43.

Makkar

Singh

Bhatia

Samra

Singh

. Fascia iliaca block for hip fractures in the emergency department: meta-analysis with trial sequential analysis. Am J Emerg Med. 2021;50:654-660.

44.

Wan

Jiang

. Fascia iliaca compartment block for perioperative pain management of geriatric patients with hip fractures: A systematic review of randomized controlled trials. Pain Res Manag. 2020;2020:8503963.

45.

Saporito

Anselmi

Sturini

Borgeat

Aguirre

. Is outpatient continuous regional analgesia more effective and equally safe than single-shot peripheral nerve blocks after ambulatory orthopedic surgery? Minerva Anestesiol. 2017;83:972-981.

46.

Bingham

Horn

Abrahams

. Continuous peripheral nerve block compared with single-injection peripheral nerve block: A systematic review and meta-analysis of randomized controlled trials. Reg Anesth Pain Med. 2012;37:583-594.

47.

Abou-Setta

Beaupre

Rashiq

, et al. Comparative effectiveness of pain management interventions for hip fracture: A systematic review. Ann Intern Med. 2011;155:234-245.

48.

Skjold

Møller

Wildgaard

. Pre-operative femoral nerve block for hip fracture-A systematic review with meta-analysis. Acta Anaesthesiol Scand. 2020;64:23-33.

49.

Rashiq

Vandermeer

Abou-Setta

Beaupre

Jones

Dryden

. Efficacy of supplemental peripheral nerve blockade for hip fracture surgery: Multiple treatment comparison. Can J Anaesth. 2013;60:230-243.

50.

Zink

Graf

. Benefit-risk assessment of ropivacaine in the management of postoperative pain. Drug Saf. 2004;27:1093-1114.

51.

Hansen

. Ropivacaine: A pharmacological review. Expert Rev Neurother. 2004;4:781-791.

Peripheral Nerve Block and Peri-operative Neurocognitive Disorders in Older Patients With Hip Fractures: A Systematic Review With Meta-analysis

Abstract

Background

Methods

Results

Conclusions

Keywords

Background

Methods

Search Strategy

Study Selection

Data Extraction

Study Quality Assessment

Statistical Analysis

Results

Study Selection

Study Characteristics

Risk of Bias Within Studies

Synthesis of Results

Primary Outcome

Secondary Outcomes

Discussion

Conclusion

Footnotes

Declaration of Conflicting Interests

Funding

PROSPERO Registration Number

ORCID iDs

Data Availability Statement

References